Quick Answer
AXIM BIOTECHNOLOGIES, INC. reported Stockholders Equity of -$7.66 million for fiscal year 2023.
AXIM BIOTECHNOLOGIES, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2023 | -$7.66M | -58.7% |
| 2022 | -$4.83M | -106.4% |
| 2021 | -$2.34M | -249.3% |
| 2020 | $1.57M | +125.7% |
| 2018 | -$6.08M | +3.2% |
| 2017 | -$6.28M | -165.0% |
| 2016 | -$2.37M | -39.9% |
| 2015 | -$1.70M | -191.9% |
| 2014 | -$580.7K | -518.3% |
| 2013 | -$93.9K | -1899.1% |
| 2012 | -$4.7K | -146.0% |
| 2011 | $10.2K | — |
| 2010 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | -$9.53M | +2.2% | -28.0% |
| March 31, 2024 | -$7.45M | -20.9% | +2.7% |
| December 31, 2023 | -$7.66M | -58.7% | -28.6% |
| September 30, 2023 | -$5.96M | -35.9% | +38.9% |
| June 30, 2023 | -$9.75M | -161.2% | -58.3% |
| March 31, 2023 | -$6.16M | -80.0% | -27.7% |
| December 31, 2022 | -$4.83M | -106.4% | -10.2% |
| September 30, 2022 | -$4.38M | -194.2% | -17.3% |
- AXIM BIOTECHNOLOGIES, INC. showed a decrease of -58.7% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from AXIM BIOTECHNOLOGIES, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 16, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: